Bluejay diagnostics announces reverse stock split

Acton, mass., july 21, 2023 (globe newswire) -- bluejay diagnostics, inc. (nasdaq: bjdx) (“bluejay” or the “company”), a medical technology company developing rapid diagnostics on its symphony platform to improve patient outcomes in critical care settings, today announced that the company's board of directors has approved a reverse stock split of its shares of common stock at a ratio of 1-for-20 (the “reverse stock split”), with a corresponding reduction in the number of authorized outstanding number of shares of common stock from 100,000,000 to 7,500,000. the reverse stock split will become effective at 12:01 a.m. eastern time on july 24, 2023, and the company's common stock will open for trading on the nasdaq capital market on a post-split basis on july 24, 2023 under the company's existing trading symbol, “bjdx.” at such time, the company's common stock will also commence trading with a new cusip number, 095633301.
BJDX Ratings Summary
BJDX Quant Ranking